Cofoe Medical Technology Co (1187) Fair Value & Analysis
Healthcare · HK · Market cap HK$7.0B
Fair value as of: Aug 13, 2026
From 24 valuation models · updated 2 days ago
Fair value updated Aug 13, 2026, revised from HK$41.09 to HK$44.66 (+8.7%) since Jul 7, 2026. Share price −3.2% over the past month.
A solid business, screening 42% undervalued on our models.
What matters now
- The rarer combination: high quality (74/100) AND below fair value. That earns a closer look rather than a quick verdict.
- The price is below even our cautious bear case (HK$34.14). The market is more pessimistic than our downside scenario.
Price vs Fair Value (3 months)
White line = price, green steps = our fair value per fiscal year. As of Aug 13, 2026.
How to read this chart
3‑month range HK$26.32 – HK$39.00 · fair‑value band HK$34.14 – HK$54.02 · the HK$31.36 price screens below the HK$44.66 fair value. As of Aug 13, 2026.
Analysis
Cofoe Medical Technology Co (1187) currently trades at HK$31.36, while our model-based Fair Value estimate is HK$44.66, implying the stock looks roughly 42.4% undervalued today. The Quality Score stands at 74/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Cofoe Medical Technology Co generated revenue of HK$3.7B at a net margin of 10.6%. Revenue grew 37.2% year over year. It earns a return on equity of 8.0%. The stock trades on a trailing P/E of 13.6 (as of Jul 2, 2026). Fundamentals as of Aug 13, 2026
Our scenario range runs from HK$34.14 (bear case) to HK$54.02 (bull case); at HK$31.36, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 24% below its 52-week high and 21% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -33% fair-value upside, at 42%, 1187 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: DCF Models (HK$45.46) versus Earnings-Based (HK$11.58). Highest evidence: Growth DCF (80).
Notify me when 1187 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 73 · Market factors (momentum, volatility) 39
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Cofoe Medical Technology Co., Ltd. engages in the research and development, production, sales, and service of home care medical devices in China. The company offers medical and wellness products for various types of diseases treatment, damage therapy, daily health maintenance, and life quality improvement.
Full company description
Cofoe Medical Technology Co., Ltd. engages in the research and development, production, sales, and service of home care medical devices in China. The company offers medical and wellness products for various types of diseases treatment, damage therapy, daily health maintenance, and life quality improvement. It also offers rehabilitation aids products, such as hearing aids, electric wheelchair, and orthopedic/posture correction products; medical care products, such as dressing products and ostomy care products; health monitoring products for monitoring human physiological parameters including metabolic disease testing product and thermometers; respiratory support products including non-invasive ventilators and nebulizers; and TCM therapy and other products, such as physiotherapy devices. Additionally, the company offers logistics and warehousing services to third party medical product companies and on-line storemanagement services. Further, the company manufactures its products through the Original Design Model, through which, it collaborates with customers to develop designs of products itmanufactures; and the original equipment manufacturing model, through which its customers provide their designs and it manufactures. The company sells its products through both offline and online channels comprising direct sales primarily via self-owned and online stores, sales to third party pharmacy chain operators, sales to offline and online distributors, and through e-commerce platforms. It sells its products through its brands Cofoe, JOYOR HearingCare, Jerry Medical, Huazhou, and babaka. The company was formerly known as Hunan Cofoe Medical Technology Development Co., Ltd. and changed its name to Cofoe Medical Technology Co.,Ltd. in December 2026. Cofoe Medical Technology Co., Ltd. was founded in 2005 and is headquartered in Changsha, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
Cofoe Medical Technology Co reported revenue of HK$3.4B in FY2025 versus HK$3.0B in FY2022, a compound +4.4%/yr. Reported net income was HK$372M in FY2025, compounding +7.2%/yr from FY2022.
Watch 1187: get an alert when its fair value changes →
Peer Group
Medical Devices · 347 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Devices median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | $110.91 | $74.79 | -33% |
| Stryker Corporation SYK | $347.21 | $186.28 | -46% |
| Medtronic plc MDT | $90.76 | $65.57 | -28% |
| Boston Scientific Corporation BSX | $51.42 | $38.44 | -25% |
| Edwards Lifesciences Corporation EW | $93.05 | $41.02 | -56% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥153.60 | ¥147.63 | -4% |
| Shanghai United Imaging Healthcare Co 688271 | ¥110.50 | ¥43.60 | -61% |
| Demant A/S DEMANT | kr 289.60 | kr 161.17 | -44% |
| Getinge AB GETIB | kr 239.30 | kr 192.14 | -20% |
| Sectra AB SECTB | kr 280.00 | kr 66.81 | -76% |
Compare Cofoe Medical Technology Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Cofoe Medical Technology Co (1187) overvalued or undervalued?
What is the fair value of 1187?
What is the quality score of 1187?
What is the revenue of Cofoe Medical Technology Co (1187)?
What is the net profit margin of 1187?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Cofoe Medical Technology Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.